Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong
· Delayed Price · Currency is HKD 76.20
-1.35 (-1.74%)
Apr 29, 2026, 4:08 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 42.15 billion as of April 29, 2026. Its market cap has increased by 128.09% in one year.
Market Cap
42.15B
Enterprise Value
45.21B
Revenue
7.42B
Ranking
n/a
PE Ratio
46.15
Stock Price
76.20
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 42.15B, an increase of 58.10%. That is a compound annual growth rate of 7.19%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Junshi Biosciences | 42.68B |
| Biocytogen Pharmaceuticals (Beijing) | 44.62B |
| 3SBio | 55.35B |
| Genscript Biotech | 30.30B |
| InnoCare Pharma | 28.40B |
| Shanghai Bao Pharmaceuticals | 26.78B |
| Duality Biotherapeutics | 25.45B |
| RemeGen | 76.50B |